← Back to all trials
Not Yet Recruiting
NCT07907146
Kinesitherapy Plus Osteopathy After Surgery for Dupuytren Disease
Conditions: Dupuytren Disease
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 50
Sponsor: Clinique Bizet
Location: Clinique Bizet Paris
Summary
This randomized, double-blind clinical trial evaluates whether adding targeted osteopathy to physiotherapy improves recovery after open surgery for Dupuytren disease.
Patients who have undergone their first open fasciectomy for Dupuytren disease will be randomly assigned to one of two groups. Both groups will receive physiotherapy. One group will additionally receive a targeted osteopathy session, while the other group will receive a sham osteopathy session.
The main objective is to evaluate recovery of extension of the metacarpophalangeal joint of the operated finger. Secondary outcomes include hand function, extension of the proximal and distal interphalangeal joints, grip strength, scar vascularization, quality of life, scar adherence, and postoperative pain.
The study will include 50 adult patients. Participants will be followed for 12 weeks, with assessments at 1, 4, 8, and 12 weeks after the start of treatment.
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 years
* Ability to provide informed consent
* Adults operated for Dupuytren disease, stages 2-3, excluding PIP deformity \>90°
* First open fasciectomy
* No participation in another clinical trial
* Affiliation with social security
* Acceptance of questionnaires
* Acceptance of 12-week follow-up
Exclusion Criteria:
* Minor
* Previous intervention on the same hand
* Associated hand conditions: symptomatic finger osteoarthritis, other major hand pathologies, significant neuropathies
* History of poor wound healing Diabetes
* Central or peripheral neurological diseases affecting the hand
* Protected adult under curatorship or guardianship
* Refusal to participate
* Pregnancy or breastfeeding
Source: ClinicalTrials.gov (NCT07907146). StuddyBuddy aggregates publicly available trial information.